Albemarle director granted 1,286 shares in stock awards

ALBEMARLE CORP director Diarmuid B. O’Connell reported stock-based compensation awards rather than open-market trades.

Rhea-AI Filing Summary

ALBEMARLE CORP director Diarmuid B. O’Connell reported stock-based compensation awards rather than open-market trades. On July 1, 2026, he acquired a total of 1,286 shares of common stock at no cash cost, recorded as grants or awards.

Footnotes explain that 36 shares are an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, scheduled to vest on July 1, 2027. Additional shares represent dividends accrued on a prior award granted on July 1, 2025 that vested on July 1, 2026, which the company settled in stock issued under the same plan.

The filing also notes that the director’s holdings were adjusted to reflect a transfer of 893 shares of common stock pursuant to an agreement of separation of assets, indicating a reallocation of previously held shares rather than a market sale.

Insider Trade Summary

Grant/Award: 1,286 shares

Grant/Award 2 txns

Insider OConnell Diarmuid B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,250	$0.00	$0.00
Grant/Award	Common Stock	36	$0.00	$0.00

Holdings After Transaction: Common Stock — 8,626 shares (Direct)

Footnotes (3)

1. F1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.
2. F2. Holdings have been adjusted to reflect a transfer of 893 shares of Common Stock pursuant to an agreement of separation of assets entered into by the Reporting Person.
3. F3. Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

Key Figures

Annual director stock installment: 36 shares Additional award shares: 1,250 shares Total shares acquired: 1,286 shares +1 more

4 metrics

Annual director stock installment 36 shares Non-employee director stock compensation vesting on July 1, 2027

Additional award shares 1,250 shares Common stock awards reported on July 1, 2026 under 2023 Directors Plan

Total shares acquired 1,286 shares Combined stock-based compensation and dividend-equivalent awards on July 1, 2026

Transferred shares 893 shares Transfer under agreement of separation of assets adjusting holdings

Key Terms

2023 Directors Plan, non-employee director stock compensation, dividends accrued, agreement of separation of assets

4 terms

2023 Directors Plan financial

"issued under the 2023 Directors Plan."

non-employee director stock compensation financial

"annual installment of non-employee director stock compensation pursuant to the 2023"

dividends accrued financial

"Represents dividends accrued on shares underlying an award granted on July 1, 2025"

agreement of separation of assets financial

"pursuant to an agreement of separation of assets entered into by the Reporting Person."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Albemarle (ALB) director Diarmuid B. O’Connell report in this Form 4?

He reported receiving 1,286 shares of Albemarle common stock as stock-based compensation awards. These included an annual director stock installment and shares issued for accrued dividends under the company’s 2023 Directors Plan, all recorded at no cash purchase price.

Were Diarmuid B. O’Connell’s Albemarle (ALB) transactions open-market purchases or compensation grants?

They were compensation-related grants, not open-market purchases. The Form 4 labels both transactions with code A for grant or award acquisitions, reflecting non-employee director stock compensation and dividend-equivalent shares under Albemarle’s 2023 Directors Plan.

When do the newly reported Albemarle (ALB) director shares vest?

The filing states that 36 shares are scheduled to vest on July 1, 2027. These represent an annual installment of non-employee director stock compensation awarded under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors.

What is Albemarle’s 2023 Directors Plan mentioned in Diarmuid B. O’Connell’s Form 4?

The 2023 Directors Plan is Albemarle’s stock compensation and deferral election plan for non-employee directors. Under this plan, director compensation and certain dividend equivalents can be delivered in shares of common stock instead of cash, as reflected in O’Connell’s reported awards.

Why were Diarmuid B. O’Connell’s Albemarle (ALB) holdings adjusted by 893 shares?

His holdings were adjusted to reflect a transfer of 893 shares of common stock. The footnote explains this occurred under an agreement of separation of assets entered into by the reporting person, indicating a reallocation of previously held shares rather than a market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:28 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OConnell Diarmuid B.

(Last) (First) (Middle)

ALBEMARLE CORPORATION

4250 CONGRESS STREET, SUITE 900

(Street)

CHARLOTTE NORTH CAROLINA 28209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		1,250(1)	A	$0	8,590(2)	D
Common Stock	07/01/2026		A		36(3)	A	$0	8,626	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

2. Holdings have been adjusted to reflect a transfer of 893 shares of Common Stock pursuant to an agreement of separation of assets entered into by the Reporting Person.

3. Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)